NorthWest Biotherapeutics Inc (NWBO)

[JerryCampbell]

Good questions, but without full Advent financials (or more detail from nwbo) we have only incomplete answers.

Since Advent operated for several years as Cognate UK, fixed assets might already be fully depreciated? That's a weak guess, that I'm not happy with, as Advent is supposed to be ramping up.

Consider some of nwbo's description of work Advent is performing.

"The Advent Agreement provided for a program initiation payment of approximately $1.0 million (£0.7 million), in connection with technology transfer and operations transfer from Germany to the U.K., to an existing facility in London, development of new Standard Operating Procedures (SOPs), training of new personnel, selection of new suppliers and auditing for GMP compliance, and other preparatory activities. Such initiation payment was fully paid by the Company as of December 31, 2018."

Sure looks like there should be both revenues and expenses.